Page last updated: 2024-10-27

glimepiride and Xeroderma Pigmentosum

glimepiride has been researched along with Xeroderma Pigmentosum in 1 studies

glimepiride: structure given in first source

Xeroderma Pigmentosum: A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA.

Research Excerpts

ExcerptRelevanceReference
"The study of xeroderma pigmentosum has yielded unforeseen advances regarding how defects in the nucleotide excision repair pathway result in this devastating disease, but development of therapeutic strategies has trailed behind the mechanistic discoveries."2.61Novel therapeutic approaches to xeroderma pigmentosum. ( Glass, DA; Weon, JL, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weon, JL1
Glass, DA1

Reviews

1 review available for glimepiride and Xeroderma Pigmentosum

ArticleYear
Novel therapeutic approaches to xeroderma pigmentosum.
    The British journal of dermatology, 2019, Volume: 181, Issue:2

    Topics: Acetohexamide; Administration, Cutaneous; Animals; Caloric Restriction; Dermatology; Disease Models,

2019